Jérôme Fayette, Aron Popovtzer, Martin David Forster, Douglas Adkins, Ye Guo, Gautier Lefebvre, Jacob Stephen Thomas, Fiona J. Collinson, Ludovic Doucet, Nathaniel Bouganim, Lei Liu, Jaafar Bennouna, Richard C. Gregory, Cong Li, Radha Ramesh, Bingyan Wu, Jeffrey Raizer, Yu-Chung Huang, Ammar Sukari. "Dose expansion data from iintune-1, a phase 1/2 study of the STING agonist dazostinag plus pembrolizumab as first-line (1L), in patients with recurrent/metastatic squamous cell carcinoma of the head and neck (RM-SCCHN).." Journal of Clinical Oncology, 2025. doi:10.1200/jco.2025.43.16_suppl.6020